On June 2, 2025, Alphamab Oncology announced that its controlling shareholder, Rubymab Ltd., entered into a share placing agreement with Morgan Stanley & Co. International plc as the sole placing agent. The announcement did not specify the total number of shares or the price involved in the transaction. The completion of the placing is subject to certain conditions, and there is no assurance that the transaction will be finalized.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.